Skip to content
Triclofos
Triclos (triclofos) is a small molecule pharmaceutical. Triclofos was first approved as Triclos on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Triclofos sodium
Tradename
Company
Number
Date
Products
TRICLOSSanofiN-016809 DISCN1982-01-01
1 products
TRICLOSSanofiN-016830 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
ecolabOTC monograph not final2023-06-08
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N05: Psycholeptics
— N05C: Hypnotics and sedatives
— N05CM: Other hypnotics and sedatives in atc
— N05CM07: Triclofos
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTRICLOFOS
INNtriclofos
Description
Triclofos is a monoalkyl phosphate.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=P(O)(O)OCC(Cl)(Cl)Cl
Identifiers
PDB—
CAS-ID306-52-5
RxCUI38610
ChEMBL IDCHEMBL1201317
ChEBI ID9695
PubChem CID5563
DrugBankDB06753
UNII IDJ712EO9048 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 211 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
362 adverse events reported
View more details